These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 38098659

  • 1. Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii.
    Rodjun V, Montakantikul P, Houngsaitong J, Jitaree K, Nosoongnoen W.
    Front Microbiol; 2023; 14():1275909. PubMed ID: 38098659
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Bian X, Liu X, Chen Y, Chen D, Li J, Zhang J.
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli.
    Jitaree K, Sathirakul K, Houngsaitong J, Asuphon O, Saelim W, Thamlikitkul V, Montakantikul P.
    Antibiotics (Basel); 2019 Aug 22; 8(3):. PubMed ID: 31443514
    [Abstract] [Full Text] [Related]

  • 5. Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study.
    Sirijatuphat R, Thawornkaew S, Ruangkriengsin D, Thamlikitkul V.
    Antibiotics (Basel); 2022 Nov 26; 11(12):. PubMed ID: 36551364
    [Abstract] [Full Text] [Related]

  • 6. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
    Liu X, Zhao M, Chen Y, Bian X, Li Y, Shi J, Zhang J.
    Int J Antimicrob Agents; 2016 Nov 26; 48(5):559-563. PubMed ID: 27670371
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Bian X, Liu X, Feng M, Bergen PJ, Li J, Chen Y, Zheng H, Song S, Zhang J.
    Int J Antimicrob Agents; 2021 Feb 26; 57(2):106271. PubMed ID: 33352235
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic profiling of four antimicrobials against Acinetobacter baumannii infection.
    Zhu W, Chu Y, Zhang J, Xian W, Xu X, Liu H.
    Microb Pathog; 2020 Jan 26; 138():103809. PubMed ID: 31634531
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of sitafloxacin tested alone and in combination with rifampin, colistin, sulbactam, and tigecycline against extensively drug-resistant Acinetobacter baumannii.
    Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L.
    Int J Clin Exp Med; 2015 Jan 26; 8(5):8135-40. PubMed ID: 26221381
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen.
    Fan Y, Li Y, Chen Y, Yu J, Liu X, Li W, Guo B, Li X, Wang J, Wu H, Wang Y, Hu J, Guo Y, Hu F, Xu X, Cao G, Wu J, Zhang Y, Zhang J, Wu X.
    Antibiotics (Basel); 2022 Jun 14; 11(6):. PubMed ID: 35740204
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of colistimethate sodium in critical patients: an in vitro study by using of Monte Carlo simulation].
    Pan A, Mei Q, Yang T, Gao X, Lu H, Ye Y, Li J, Liu B.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May 14; 29(5):385-389. PubMed ID: 28524024
    [Abstract] [Full Text] [Related]

  • 15. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S, Grau S, Valle M, Sorlí L, Horcajada JP, Segura C, Alvarez-Lerma F.
    Int J Antimicrob Agents; 2013 Aug 14; 42(2):178-81. PubMed ID: 23769664
    [Abstract] [Full Text] [Related]

  • 16. Clinical Efficacy of Sitafloxacin-Colistin-Meropenem and Colistin-Meropenem in Patients with Carbapenem-Resistant and Multidrug-Resistant Acinetobacter baumannii Hospital-Acquired Pneumonia (HAP)/Ventilator-Associated Pneumonia (VAP) in One Super-Tertiary Hospital in Bangkok, Thailand: A Randomized Controlled Trial.
    Wantanatavatod M, Wongkulab P.
    Antibiotics (Basel); 2024 Jan 30; 13(2):. PubMed ID: 38391523
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
    Kaye KS, Shorr AF, Wunderink RG, Du B, Poirier GE, Rana K, Miller A, Lewis D, O'Donnell J, Chen L, Reinhart H, Srinivasan S, Isaacs R, Altarac D.
    Lancet Infect Dis; 2023 Sep 30; 23(9):1072-1084. PubMed ID: 37182534
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W, Cui J, Liang B, Cai Y, Bai N, Cai X, Wang R.
    J Antibiot (Tokyo); 2013 Dec 30; 66(12):705-8. PubMed ID: 23981963
    [Abstract] [Full Text] [Related]

  • 20. Colistin Dosing Regimens against Pseudomonas aeruginosa in Critically Ill Patients: An Application of Monte Carlo Simulation.
    Nguyen VTK, Montakantikul P, Tragulpiankit P, Houngsaitong J, Shuib MF.
    Antibiotics (Basel); 2021 May 17; 10(5):. PubMed ID: 34067716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.